In mouse tumor models, CRISPR screening was performed, revealing a significant loss of tumor suppressor genes (TSGs) and a notable enrichment of CCL2/MCP1 genes, along with an accumulation of MDSCs [74]. Here, CCL2 is linked to neoplasm.